The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(((2S,3S)-3-((S)-1-(3,5-Dichlorophenyl)-2-hydroxyethoxy)-2-phenylpiperidin-1-yl)methyl)-1H-benzo(d)imidazole-6-carboxylic Acid ID: ALA5207745
PubChem CID: 168294949
Max Phase: Preclinical
Molecular Formula: C28H27Cl2N3O4
Molecular Weight: 540.45
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1ccc2nc(CN3CCC[C@H](O[C@H](CO)c4cc(Cl)cc(Cl)c4)[C@@H]3c3ccccc3)[nH]c2c1
Standard InChI: InChI=1S/C28H27Cl2N3O4/c29-20-11-19(12-21(30)14-20)25(16-34)37-24-7-4-10-33(27(24)17-5-2-1-3-6-17)15-26-31-22-9-8-18(28(35)36)13-23(22)32-26/h1-3,5-6,8-9,11-14,24-25,27,34H,4,7,10,15-16H2,(H,31,32)(H,35,36)/t24-,25+,27-/m0/s1
Standard InChI Key: SSOFDNCUHHHDAD-WEWMWRJBSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
-0.1018 -1.1132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1019 -0.2882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8162 0.1241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8162 0.9490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1019 1.3615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6125 0.9490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3269 1.3615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3269 2.1865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6125 2.5989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1019 2.1865 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0413 2.5989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0413 3.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7557 3.8363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7557 4.6612 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.4702 3.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4702 2.5989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1845 2.1865 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.7557 2.1865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6125 0.1241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3269 -0.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3269 -1.1132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0413 -1.5257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7557 -1.1132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7557 -0.2882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0413 0.1241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8162 -1.5257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9025 -2.3461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7094 -2.5176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1218 -1.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9467 -1.8032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9467 -3.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1218 -3.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5698 -1.1901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3592 -2.5176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3593 -3.9466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9467 -4.6612 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.1845 -3.9466 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
4 5 1 0
6 5 1 0
6 7 1 6
7 8 1 0
8 9 1 6
9 10 1 0
8 11 1 0
12 11 2 0
13 12 1 0
13 14 1 0
15 13 2 0
16 15 1 0
16 17 1 0
18 16 2 0
11 18 1 0
19 6 1 0
2 19 1 0
19 20 1 6
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 20 2 0
1 26 1 0
27 26 1 0
27 28 1 0
28 29 2 0
29 30 1 0
28 32 1 0
31 32 2 0
29 33 1 0
33 26 2 0
30 34 2 0
34 31 1 0
31 35 1 0
35 36 2 0
35 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 540.45Molecular Weight (Monoisotopic): 539.1379AlogP: 6.02#Rotatable Bonds: 8Polar Surface Area: 98.68Molecular Species: ACIDHBA: 5HBD: 3#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.68CX Basic pKa: 6.70CX LogP: 2.94CX LogD: 2.34Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.25Np Likeness Score: -0.62
References 1. Mak VW, Patel AM, Yen R, Hanisak J, Lim YH, Bao J, Zheng R, Seganish WM, Yu Y, Healy DR, Ogawa A, Ren Z, Soriano A, Ermakov GP, Beaumont M, Metwally E, Cheng AC, Verras A, Fischmann T, Zebisch M, Silvestre HL, McEwan PA, Barker J, Rearden P, Greshock TJ.. (2022) Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1α., 65 (15.0): [PMID:35878399 ] [10.1021/acs.jmedchem.1c02109 ]